Single-strain probiotics enhance growth, anti-pathogen immunity, and resistance to Nocardia seriolae in grey mullet (Mugil cephalus) via gut microbiota modulation.

IF 4.9 Q1 MICROBIOLOGY
Ching-Hung Chan, Li-Han Chen, Kuang-Yu Chen, I-Hung Chen, Kung-Ta Lee, Liang-Chuan Lai, Mong-Hsun Tsai, Eric Y Chuang, Ming-Tse Lin, Tsong-Rong Yan
{"title":"Single-strain probiotics enhance growth, anti-pathogen immunity, and resistance to Nocardia seriolae in grey mullet (Mugil cephalus) via gut microbiota modulation.","authors":"Ching-Hung Chan, Li-Han Chen, Kuang-Yu Chen, I-Hung Chen, Kung-Ta Lee, Liang-Chuan Lai, Mong-Hsun Tsai, Eric Y Chuang, Ming-Tse Lin, Tsong-Rong Yan","doi":"10.1186/s42523-024-00353-0","DOIUrl":null,"url":null,"abstract":"<p><p>Grey mullet (Mugil cephalus) aquaculture is economically vital due to the high value of its roe. However, it faces significant risks from disease outbreaks, particularly from Nocardia seriolae. Current reliance on antibiotics has drawbacks, highlighting the potential of probiotics as a promising alternative. Despite this, no studies have focused on the effects and mechanisms of probiotics in disease prevention and treatment in grey mullet. This study, therefore, investigates the efficacy of probiotics in enhancing disease resistance and promoting growth in grey mullet. Three strains of probiotics, Lacticaseibacillus rhamnosus FS3051, Limosilactobacillus reuteri FS3052, and Bacillus subtilis natto NTU-18, were selected to evaluate their anti-N. seriolae activity and hydrolytic enzyme secretion in vitro. Then, 144 grey mullet were randomly divided into four groups: control, L. rhamnosus FS3051, L. reuteri FS3052, and B. subtilis natto NTU-18. After being fed the corresponding diet for 28 days, fish were measured for immune gene expression and short-term growth followed by challenge of N. seriolae. Survival rates were recorded for 35 days post challenge. Additionally, the gut microbiota of the control and probiotic groups with effects on both growth and protection against N. seriolae were analyzed to investigate the potential role of gut microbiota. Results demonstrated that L. rhamnosus FS3051 and L. reuteri FS3052 inhibited N. seriolae, while B. subtilis natto NTU-18 did not inhibited N. seriolae. Probiotics also had the ability to secrete hydrolytic enzymes. Probiotic-fed grey mullet showed significant improvements in weight gain ratio, feed efficiency, and specific growth rate, particularly in the B. subtilis natto NTU-18 group. Immune gene expression was enhanced by probiotics, especially L. rhamnosus, FS3051, which induced IL-8, IL-1β, TNF-α, IFN-γ, and MHCI. Survival rates post-N. seriolae challenge improved significantly for L. rhamnosus FS3051-fed fish. L. rhamnosus FS3051 also altered the gut microbiota, enriching beneficial genera like Lactobacillus, which correlated positively with immune responses and growth, while reducing Mycoplasma and Rhodobacter, which were negatively correlated with immune responses. This study underscores the potential of probiotics in enhancing disease resistance and growth via regulating gut microbiota in grey mullet.</p>","PeriodicalId":72201,"journal":{"name":"Animal microbiome","volume":"6 1","pages":"67"},"PeriodicalIF":4.9000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Animal microbiome","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s42523-024-00353-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Grey mullet (Mugil cephalus) aquaculture is economically vital due to the high value of its roe. However, it faces significant risks from disease outbreaks, particularly from Nocardia seriolae. Current reliance on antibiotics has drawbacks, highlighting the potential of probiotics as a promising alternative. Despite this, no studies have focused on the effects and mechanisms of probiotics in disease prevention and treatment in grey mullet. This study, therefore, investigates the efficacy of probiotics in enhancing disease resistance and promoting growth in grey mullet. Three strains of probiotics, Lacticaseibacillus rhamnosus FS3051, Limosilactobacillus reuteri FS3052, and Bacillus subtilis natto NTU-18, were selected to evaluate their anti-N. seriolae activity and hydrolytic enzyme secretion in vitro. Then, 144 grey mullet were randomly divided into four groups: control, L. rhamnosus FS3051, L. reuteri FS3052, and B. subtilis natto NTU-18. After being fed the corresponding diet for 28 days, fish were measured for immune gene expression and short-term growth followed by challenge of N. seriolae. Survival rates were recorded for 35 days post challenge. Additionally, the gut microbiota of the control and probiotic groups with effects on both growth and protection against N. seriolae were analyzed to investigate the potential role of gut microbiota. Results demonstrated that L. rhamnosus FS3051 and L. reuteri FS3052 inhibited N. seriolae, while B. subtilis natto NTU-18 did not inhibited N. seriolae. Probiotics also had the ability to secrete hydrolytic enzymes. Probiotic-fed grey mullet showed significant improvements in weight gain ratio, feed efficiency, and specific growth rate, particularly in the B. subtilis natto NTU-18 group. Immune gene expression was enhanced by probiotics, especially L. rhamnosus, FS3051, which induced IL-8, IL-1β, TNF-α, IFN-γ, and MHCI. Survival rates post-N. seriolae challenge improved significantly for L. rhamnosus FS3051-fed fish. L. rhamnosus FS3051 also altered the gut microbiota, enriching beneficial genera like Lactobacillus, which correlated positively with immune responses and growth, while reducing Mycoplasma and Rhodobacter, which were negatively correlated with immune responses. This study underscores the potential of probiotics in enhancing disease resistance and growth via regulating gut microbiota in grey mullet.

单菌株益生菌通过调节肠道微生物群提高鲻鱼(Mugil cephalus)的生长、抗病原免疫力和对Nocardia seriolae的抵抗力。
鲻鱼(Mugil cephalus)水产养殖因其鱼子的高价值而具有重要的经济意义。然而,它也面临着疾病爆发的巨大风险,尤其是血清诺卡氏菌(Nocardia seriolae)。目前对抗生素的依赖存在弊端,这凸显了益生菌作为一种有前途的替代品的潜力。尽管如此,还没有研究关注益生菌在鲻鱼疾病预防和治疗中的作用和机制。因此,本研究调查了益生菌在增强鲻鱼抗病能力和促进生长方面的功效。本研究选取了三株益生菌(鼠李糖乳酸杆菌 FS3051、雷氏乳酸菌 Limosilactobacillus reuteri FS3052 和纳豆芽孢杆菌 Bacillus subtilis natto NTU-18),对其体外抗N. seriolae活性和水解酶分泌进行了评估。然后,将 144 尾灰鲻鱼随机分为四组:对照组、鼠李糖球菌 FS3051 组、沙门氏菌 FS3052 组和枯草芽孢杆菌纳豆 NTU-18 组。在喂食相应饲料 28 天后,测量鱼的免疫基因表达和短期生长情况,然后对其进行 N. seriolae 挑战。记录了挑战后 35 天的存活率。此外,还分析了对照组和益生菌组的肠道微生物群,以研究肠道微生物群的潜在作用。结果表明,鼠李糖FS3051和罗伊氏菌FS3052能抑制N. seriolae,而枯草芽孢杆菌Natto NTU-18不能抑制N. seriolae。益生菌还能分泌水解酶。益生菌喂养的鲻鱼在增重比、饲料效率和特定生长率方面都有显著改善,尤其是在纳豆益生菌NTU-18组。益生菌可增强免疫基因的表达,尤其是鼠李糖,FS3051,可诱导 IL-8、IL-1β、TNF-α、IFN-γ 和 MHCI。饲喂鼠李糖球菌 FS3051 的鱼在受到 N. seriolae 挑战后的存活率明显提高。鼠李糖FS3051还改变了肠道微生物群,丰富了乳酸杆菌等有益菌属,这些菌属与免疫反应和生长呈正相关,同时减少了支原体和罗杆菌,这些菌属与免疫反应呈负相关。这项研究强调了益生菌通过调节鲻鱼肠道微生物群增强抗病能力和生长的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.20
自引率
0.00%
发文量
0
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信